Medpace

clinical research clinical development medpace clinical trials drug development cro rare diseases late phase oncology clinical operations biomarker laboratory clinical trial precision medicine rare disease compliance pediatric pharmacoeconomic assessment clinical pharmacology quality assurance mike winegar immuno-oncology advanced therapies outcomes research covid-19 risk management medical device regulatory approval radiopharmaceuticals observational studies patient registries phase i asia cpu xiaoxiong wei drug development china regulatory compliance china jim wei cincinnati early phase medpace medical device medical device medical device regulatory reform medical device clinical trial pivotal device trials safety device trials fim device trials regulatory compliance dr. ursula schlichtiger medpace medical consulting alzheimers's outsourcing strategy strategic partnering debbie elliott separate tags by comstrategic partnership medpacema jimwei fda china biosimilars regulatory risk-based monitoring hematology commercialized medical devices sponsor regulatory affairs relationships neuroscience imaging patient recruitment cancer pediatric cancer research acute myeloid leukemia radiation therapy chronic kidney disease cell therapies gene therapies dosimetry cardiovascular biomarkers phase i/iia phase iiib phase iv observastion studies randomised clinical trials safety efficacy studies clinical studies expanded access programs randomized clinical trials registries safety surveillance post-authorization studies orphan drug safety pharmacovigilance audits surveillance good clinical practice market approval pharmaceutical asia pacific